COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,050 Articles (22,627 medRxiv, 8,423 bioRxiv)

Most recent first Previous |  Page 1030: Articles 10291-10300  | Next

Therapies for Long COVID in non-hospitalised individuals - from symptoms, patient-reported outcomes, and immunology to targeted therapies (The TLC Study): Study protocol
Haroon, S., Nirantharakumar, K., Hughes, S., Subramanian, A., Aiyegbusi, O. L., Davies, E. H., Myles, P., Williams, T., Turner, G., Chandan, J. S., McMullan, C., Lord, J., Wraith, D., McGee, K., Denniston, A., Taverner, T., Jackson, L., Sapey, E., Gkoutos, G., Gokhale, K., Leggett, E., Iles, C., Frost, C., McNamara, G., Bamford, A., Marshall, T., Zemedikun, D., Price, G., Marwaha, S., Simms-Williams, N., Brown, K., Walker, A., Jones, K., Matthews, K., Camaradou, J., Saint-Cricq, M., Kumar, S., Alder, Y., Stanton, D., Agyen, L., Baber, M., Blaize, H., Calvert, M.
10.1101/2021.12.20.21268098 — Posted: 2021-12-21
Time Between Viral Loads for People with HIV during the COVID-19 Pandemic
El-Nahal, W. G., Shen, N. M., Keruly, J. C., Jones, J. L., Fojo, A. T., Manabe, Y. C., Moore, R. D., Gebo, K. A., Chander, G., Lesko, C. R.
10.1101/2021.12.19.21268052 — Posted: 2021-12-21
High-Quality and Easy-to-Regenerate Personal Filter
Fraenkl, M., Krbal, M., Houdek, J., Zmrhalova, Z. O., Prokes, B., Hejda, P., Slang, S., Prikryl, J., Ondracek, J., Makes, O., Kostyk, J., Nasadil, P., Malcik, P., Zdimal, V., Vlcek, M.
10.1101/2021.12.16.21267766 — Posted: 2021-12-21
Orthostatic intolerance in adults with long COVID was not associated with postural orthostatic tachycardia syndrome
Monaghan, A., Jennings, G., Xue, F., Byrne, L., Duggan, E., Romero-Ortuno, R.
10.1101/2021.12.19.21268060 — Posted: 2021-12-21
Pentosan polysulfate inhibits attachment and infection by SARS-CoV-2 in vitro: insights into structural requirements for binding.
Bertini, S., Alekseeva, A., Elli, S., Pagani, I., Zanzoni, S., Eisele, G., Krishnan, R., Maag, K. P., Reiter, C., Lenhart, D., Gruber, R., Yates, E. A., Vicenzi, E., Naggi, A., Bisio, A., Guerrini, M.
10.1101/2021.12.19.473359 — Posted: 2021-12-21
SARS-CoV-2 vaccine effectiveness and breakthrough infections in maintenance dialysis patients
Manley, H. J., Aweh, G., Hsu, C. M., Weiner, D. E., Miskulin, D., Harford, A. M., Johnson, D., Lacson, E. K.
10.1101/2021.12.20.21268124 — Posted: 2021-12-21
Activity of convalescent and vaccine serum against a B.1.1.529 variant SARS-CoV-2 isolate
Carreno, J. M., Alshammary, H., Tcheou, J., Singh, G., Raskin, A., Kawabata, H., Sominsky, L., Clark, J., Adelsberg, D. C., Bielak, D., Gonzalez-Reiche, A. S., Study Group, P., Srivastava, K., Sordillo, E. M., Bajic, G., van Bakel, H., Simon, V., Krammer, F.
10.1101/2021.12.20.21268134 — Posted: 2021-12-21
Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen
Nayrac, M., Dube, M., Sannier, G., Nicolas, A., Marchitto, L., Tastet, O., Tauzin, A., Brassard, N., Beaudoin-Bussieres, G., Vezina, D., Gong, S. Y., Benlarbi, M., Gasser, R., Laumaea, A., Bourassa, C., Gendron-Lepage, G., Medjahed, H., Goyette, G., Ortega-Delgado, G.-G., Laporte, M., Niessl, J., Gokool, L., Morrisseau, C., Arlotto, P., Richard, J., Tremblay, C., Martel-Laferriere, V., Finzi, A., Kaufmann, D. E.
10.1101/2021.12.18.473317 — Posted: 2021-12-21
Sentimental Tweets Classification of Symptomatic COVID 19
P, T.
10.1101/2021.12.15.472745 — Posted: 2021-12-21
Epidemiology study of SARS-CoV-2 pandemic in India, the first and second wave
Chaudhuri, D., Datta, J., Majumder, S., Giri, K.
10.1101/2021.12.20.21268016 — Posted: 2021-12-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).